Canhua Yun

发表

Could urinary iodine be an effective predictive factor for thyroid cancer after high dose radioactive iodine therapy?

Wei Zhang, Jingjia Cao, Canhua Yun, 2022, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Potential Impact of Body Mass Index on the Clinical Outcome of Papillary Thyroid Cancer After High-Dose Radioactive Iodine Therapy

Wei Zhang, Jingjia Cao, Canhua Yun, 2022, Frontiers in Endocrinology.

The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer

Jingjia Cao, Canhua Yun, Xiaolu Zhu, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy

Juan Xiao, Yong Liu, Jingjia Cao, 2021, Cancer management and research.

A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients

Shouluan Ding, Juan Xiao, C. Shao, 2021, Scientific Reports.

Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine

Juan Xiao, C. Shao, Hongying Jia, 2021, Cancer medicine.

Clinical Analysis of the Short-Term Outcome of Papillary Thyroid Micro Carcinoma After 131I Treatment

Ya-jing Sun, Jingjia Cao, Canhua Yun, 2021, Cancer management and research.

CMAR_A_308012 4691..4698

Wei Zhang, Jingjia Cao, Canhua Yun, 2021 .

Comparative diagnostic accuracy of respective nuclear imaging for suspected fracture-related infection: a systematic review and Bayesian network meta-analysis

Fanxiao Liu, Dongsheng Zhou, Jin-lei Dong, 2020, Archives of Orthopaedic and Trauma Surgery.

The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study

Nan Wang, H. Xie, P. Nie, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer

Jingjia Cao, Canhua Yun, Xiaolu Zhu, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies

Fanxiao Liu, Dongsheng Zhou, Yelong Shen, 2021, Frontiers in Oncology.

Delay of initial radioactive iodine therapy beyond 3 months has no effect on clinical responses and overall survival in patients with thyroid carcinoma: A cohort study and a meta‐analysis

Shouluan Ding, Juan Xiao, C. Shao, 2022, Cancer medicine.

Preablative Stimulated Thyroglobulin and Thyroglobulin Reduction Index as Decision-Making Markers for Second Radioactive Iodine Therapy in Patients with Structural Incomplete Response

Juan Xiao, Hongying Jia, F. Huang, 2021, Cancer management and research.

Analysis of the incidence and influencing factors of hyponatremia before 131I treatment of differentiated thyroid carcinoma

Juan Xiao, Yong Liu, Jingjia Cao, 2021, World journal of clinical cases.